CN Patent

CN101358201A — 重组人铁调素腺病毒、其制备方法及应用

Assigned to HKUST Shenzhen Research Institute · Expires 2009-02-04 · 17y expired

What this patent protects

本发明公开了一种重组人铁调素腺病毒(Ad－hepc)，包含有人铁调素(hepcidin)基因与腺病毒载体。本发明还公开了上述重组人铁调素腺病毒的制备及其应用。本发明是利用缺陷型腺病毒将人铁调素(hepcidin)基因引入机体组织细胞，使病毒能在患者体内自主表达铁调素蛋白。

USPTO Abstract

本发明公开了一种重组人铁调素腺病毒(Ad－hepc)，包含有人铁调素(hepcidin)基因与腺病毒载体。本发明还公开了上述重组人铁调素腺病毒的制备及其应用。本发明是利用缺陷型腺病毒将人铁调素(hepcidin)基因引入机体组织细胞，使病毒能在患者体内自主表达铁调素蛋白。

Drugs covered by this patent

Patent Metadata

Patent number: CN101358201A
Jurisdiction: CN
Classification: —
Expires: 2009-02-04
Drug substance claim: No
Drug product claim: No
Assignee: HKUST Shenzhen Research Institute
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.